Physician profile
Cameron Olsen
NPI 1285252973
$699.76
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $206 · 2021: $397 · 2022: $97.47.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $202.23 | 2020-2022 | |
| Novo Nordisk INC | $168.82 | 2020-2021 | |
| Amarin Pharma, INC. | $67.12 | 2020-2021 | |
| Amgen INC. | $36.54 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.10 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.68 | 2021 | |
| Esperion Therapeutics, INC. | $19.32 | 2020 | |
| Merck Sharp & Dohme LLC | $16.80 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.48 | 2022 | |
| Abbvie INC. | $16.08 | 2022 | |
| Pfizer INC. | $15.60 | 2022 | |
| Mylan Specialty L.P. | $13.70 | 2020 | |
| Glaxosmithkline, LLC. | $12.84 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.